Abstract
Background
We reported a modification of the hepatic portoenterostomy (HPE) for biliary atresia with favorable results. HPE is associated with a risk of hepatic impairment, so we adopted a novel steroid therapy regimen well suited to our procedure. This paper reports the results of our experience.
Patients and methods
Between 1991 and 2009, 53 patients (18 boys, 35 girls) underwent modified HPE with novel steroid therapy, which consisted of administering hydrocortisone immediately after surgery, followed by intravenous administration of prednisolone. The number of patients who became normal total bilirubin (TB) levels, frequency of early onset cholangitis and other postoperative complications, and outcomes were retrospectively studied.
Results
The TB levels in 43 of the 53 patients became normal. Cholangitis was observed in seven, but all of them recovered. Other postoperative complications were noted in eight, but with no fatal cases. Of the 11 patients who underwent living-donor liver transplantation, 3 died after the transplant. Of the 53 patients, 39 are alive without liver transplantation and 34 have normal TB (range of observation period: 18 years and 9–2 months).
Conclusions
The novel steroid regimen may have contributed to the outcome and appears to be well suited to the modified HPE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hashimoto T, Otobe Y, Shimizu Y, Suzuki T, Nakamura T, Hayashi S, Matsuo Y, Sato M, Manabe T (1997) A modification of hepatic portoenterostomy (Kasai operation) for biliary atresia. J Am Coll Surg 185:548–553
Karrer FM, Lilly JR (1985) Corticosteroid therapy in biliary atresia. J Pediatr Surg 20:693–695
Dillon PW, Owings E, Cilley R, Field D, Curnow A, Georgeson K (2001) Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg 36:80–85
Miner PB, Gaito JM (1979) Bile flow in response to pharmacologic agents: hepatic DNA as a reference standard. Biochem Pharmacol 28:1063–1066
Howard ER (1988) Biliary atresia. In: Blumgart LH (ed) Surgery of liver and biliary tract. Churchill Livingstone, Edinburgh, pp 707–720
Meyers RL, Book LS, O’Gorman MA, Jackson WD, Black RE, Johnson DG, Matlak ME (2003) High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants. J Pediatr Surg 38:406–411
Kotb MA (2008) Review of historical cohort: urusodeoxycholic acid in extrahepatic biliary atresia. J Pediatri Surg 43:1321–1327
Willot S, Uhlen S, Michaud L, Briand G, Bonnevalle M, Sfeir R, Gottrand F (2008) Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia. Pediatrics 122:e1236–e1241
Escobar MA, Jay CL, Brooks RM, West KW, Rescorla FJ, Molleston JP, Grosfeld JL (2006) Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediat Surg 41:99–103
Muraji T, Nio M, Ohhama Y, Hashimoto T, Iwanaka T, Takamatsu H, Ohnuma N, Kato T, Ohi R, Society Japanese Biliary Atresia (2004) Postoperative corticosteroid therapy for bile drainage in biliary atresia: a nationwide survey. J Pediatr Surg 39:1803–1805
Stringer MD, Davison SM, Rajwal SR, McClean P (2007) Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. J Pediatr Surg 42:1324–1328
The Japanese Biliary Atresia Society (2010) The nationwide survey for biliary atresia. J Jpn Soc Pediatr Surg 46:284–295
Chung HY, Kak Yuen Wong K, Cheun Leung Lan L, Kwong Hang Tam P (2008) Evaluation of standardized protocol in the use of steroids after Kasai operation. Pediatr Surg Int 24:1001–1004
Kobayashi H, Yamataka A, Koga H, Okazaki T, Tamura T, Urao M, Yanai T, Lane GJ, Miyano T (2005) Optimum prednisolone usage in patients with biliary atresia postportenterostomy. J Pediatr Surg 40:327–330
Takekawa Y, Muraji T, Tsugawa C (2005) Glycocorticoid receptor α expression on the intrahepatic biliary epithelium and adjuvant steroid therapy in infants with biliary atresia. J Pediatr Sueg 40:1574–1580
Paterson C, Harder D, Melter M, Becker T, Wasielewski R, Leonhardt J, Ure BM (2008) Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol 103:712–719
Davenport M, Stringer MD, Tizzard SA, McClean P, Mieli-Vergani G, Hadzic N (2007) Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology 46:1821–1827
Erlichman J, Hohlweg K, Haber BA (2009) Biliary atresia: how medical complications and therapies impact outcome. Expert Rev Gastroenterol Hepatol 3:425–434
Vejchapipat P, Passakonnirin R, Sookpotarom P, Chittmittrapap S, Poovorawan Y (2007) HIgh-dose steroids do not improve early outcome biliary atresia. J Pediatr Surg 42:2102–2105
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suzuki, T., Hashimoto, T., Kondo, S. et al. Evaluating patients’ outcome post-Kasai operation: a 19-year experience with modification of the hepatic portoenterostomy and applying a novel steroid therapy regimen. Pediatr Surg Int 26, 825–830 (2010). https://doi.org/10.1007/s00383-010-2637-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-010-2637-y